Skip to main content

Advertisement

SpringerLink
Log in

Low rates of osteoporosis treatment after hospitalization for hip fracture in Hawaii

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

We evaluated osteoporosis treatment and DEXA utilization rates of patients who were admitted for hip fracture in a single healthcare system in Hawaii from 2015 to 2016. We found that osteoporosis treatment and DEXA utilization rates were low, highlighting a critical gap in osteoporosis care after admission for hip fracture.

Introduction

The objective of this study was to evaluate osteoporosis care after an admission for hip fracture at three community hospitals within a single healthcare system in Hawaii.

Methods

A retrospective chart review was conducted (n = 428) of patients ≥ 50 years and hospitalized for hip fractures between January 1, 2015, and May 31, 2016, at three major hospitals within Hawaii Pacific Health, a large healthcare system in Hawaii. Basic demographics were collected, and medications prescribed were quantified and described within 1 year of hip fracture. Logistic regression was used to evaluate the association between collected variables and the odds of osteoporosis treatment.

Results

Only 115 (26.9%) patients were prescribed a medication for osteoporosis as a secondary prevention within a year of hospitalization for hip fracture. DEXA scans were performed in 137 (32.0%) patients. Most of the treated patients were prescribed oral bisphosphonates. Treatment facility, female gender, and higher BMI were found to be predictive factors for osteoporosis treatment.

Conclusion

The use of osteoporosis medication for secondary prevention after admission for hip fracture in Hawaii is low. Efforts need to be made to improve treatment rates, especially among males.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lim SY, Bolster MB (2015) Current approaches to osteoporosis treatment. Curr Opin Rheumatol 27:216–224

    Article  PubMed  CAS  Google Scholar 

  2. Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761–1767

    Article  PubMed  Google Scholar 

  3. Foster K (2017) Hip fractures in adults. UpToDate, Waltham

    Google Scholar 

  4. Colon-Emeric CS, Sloane R, Hawkes WG, Magaziner J, Zimmerman SI, Pieper CF, Lyles KW (2000) The risk of subsequent fractures in community-dwelling men and male veterans with hip fracture. Am J Med 109:324–326

    Article  PubMed  CAS  Google Scholar 

  5. Drew S, Judge A, Cooper C, Javaid M, Farmer A, Gooberman-Hill R (2016) Secondary prevention of fractures after hip fracture: a qualitative study of effective service delivery. Osteoporos Int 27:1719–1727

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Sale JE, Beaton D, Bogoch E (2014) Secondary prevention after an osteoporosis-related fracture: an overview. Clin Geriatr Med 30:317–332

    Article  PubMed  Google Scholar 

  7. Harrington JT, Broy SB, Derosa AM, Licata AA, Shewmon DA (2002) Hip fracture patients are not treated for osteoporosis: a call to action. Arthritis Care Res 47:651–654

    Article  Google Scholar 

  8. MacLean C, Newberry S, Maglione M, McMahon M, Ranganath V, Suttorp M, Mojica W, Timmer M, Alexander A, McNamara M (2008) Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis preventing fractures in people with low bone density or osteoporosis. Ann Intern Med 148:197–213

    Article  PubMed  Google Scholar 

  9. Kim SC, Kim M-S, Sanfélix-Gimeno G, Song HJ, Liu J, Hurtado I, Peiró S, Lee J, Choi N-K, Park B-J (2015) Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study. Am J Med 128:519–526. e511

    Article  PubMed  PubMed Central  Google Scholar 

  10. Dickson M, Plauschinat CA (2008) Racial differences in medication compliance and healthcare utilization among hypertensive Medicaid recipients: fixed-dose vs free-combination treatment. Ethn Dis 18:204–209

    PubMed  Google Scholar 

  11. Varney JM, Okamoto GA, Goebert DA (1992) Hospitalizations for hip fractures among elderly persons in Hawaii, 1986-1990. Arch Phys Med Rehabil 73:752–757

    PubMed  CAS  Google Scholar 

  12. Gerber BS, Cho YI, Arozullah AM, Lee SY (2010) Racial differences in medication adherence: a cross-sectional study of Medicare enrollees. Am J Geriatr Pharmacother 8:136–145

    Article  PubMed  PubMed Central  Google Scholar 

  13. Hamrick I, Whetstone LM, Cummings DM (2006) Racial disparity in treatment of osteoporosis after diagnosis. Osteoporos Int 17:1653–1658

    Article  PubMed  CAS  Google Scholar 

  14. Tanne JH (2007) Is Wisconsin or Hawaii the healthiest US state? BMJ 334:1293

    PubMed  PubMed Central  Google Scholar 

  15. Hawaii Pacific Health (2017) Hawaii Pacific Health—about us. https://www.hawaiipacifichealth.org/about-us/overview/ Accessed 20 Nov 2017

  16. McClung MR, Grauer A, Boonen S et al (2014) Romosozumab in postmenopausal women with low bone mineral density. N Engl J Med 370:412–420

    Article  PubMed  CAS  Google Scholar 

  17. Solomon DH, Johnston SS, Boytsov NN, McMorrow D, Lane JM, Krohn KD (2014) Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011. J Bone Miner Res 29:1929–1937

    Article  PubMed  PubMed Central  Google Scholar 

  18. Weaver J, Sajjan S, Lewiecki EM, Harris ST (2017) Diagnosis and treatment of osteoporosis before and after fracture: a side-by-side analysis of commercially insured and Medicare advantage osteoporosis patients. J Manag Care Spec Pharm 23:735–744

    Article  PubMed  Google Scholar 

  19. Antonelli M, Einstadter D, Magrey M (2014) Screening and treatment of osteoporosis after hip fracture: comparison of sex and race. J Clin Densitom 17:479–483

    Article  PubMed  Google Scholar 

  20. Gillespie CW, Morin PE (2017) Trends and disparities in osteoporosis screening among women in the United States, 2008-2014. Am J Med 130:306–316

    Article  PubMed  Google Scholar 

  21. Kaufman JD, Bolander ME, Bunta AD, Edwards BJ, Fitzpatrick LA, Simonelli C (2003) Barriers and solutions to osteoporosis care in patients with a hip fracture. J Bone Joint Surg Am 85-A:1837–1843

    Article  PubMed  Google Scholar 

  22. Sale J, Bogoch E, Hawker G, Gignac M, Beaton D, Jaglal S, Frankel L (2014) Patient perceptions of provider barriers to post-fracture secondary prevention. Osteoporos Int 25:2581–2589

    Article  PubMed  CAS  Google Scholar 

  23. Beaton D, Dyer S, Jiang D, Sujic R, Slater M, Sale J, Bogoch E, Team OFCSPE (2014) Factors influencing the pharmacological management of osteoporosis after fragility fracture: results from the Ontario osteoporosis strategy’s fracture clinic screening program. Osteoporos Int 25:289–296

    Article  PubMed  CAS  Google Scholar 

  24. Yu J, Brenneman SK, Sazonov V, Modi A (2015) Reasons for not initiating osteoporosis therapy among a managed care population. Patient Prefer Adherence 9:821

    PubMed  PubMed Central  Google Scholar 

  25. Marsh D, Akesson K, Beaton DE et al (2011) Coordinator-based systems for secondary prevention in fragility fracture patients. Osteoporos Int 22:2051–2065

    Article  PubMed  CAS  Google Scholar 

  26. Newman ED (2011) Perspectives on pre-fracture intervention strategies: the Geisinger health system osteoporosis program. Osteoporos Int 22(Suppl 3):451–455

    Article  PubMed  Google Scholar 

  27. Dell R (2011) Fracture prevention in Kaiser Permanente Southern California. Osteoporos Int 22(Suppl 3):457–460

    Article  PubMed  Google Scholar 

  28. Cawthon PM (2011) Gender differences in osteoporosis and fractures. Clin Orthop Relat Res 469:1900–1905

    Article  PubMed  PubMed Central  Google Scholar 

  29. Mendelson DA, Friedman SM (2014) Principles of comanagement and the geriatric fracture center. Clin Geriatr Med 30:183–189

    Article  PubMed  Google Scholar 

  30. Counterweight Project Te (2005) The impact of obesity on drug prescribing in primary care. Br J Gen Pract 55:743–749

    Google Scholar 

  31. Cowie MR, Blomster JI, Curtis LH, Duclaux S, Ford I, Fritz F, Goldman S, Janmohamed S, Kreuzer J, Leenay M, Michel A, Ong S, Pell JP, Southworth MR, Stough WG, Thoenes M, Zannad F, Zalewski A (2017) Electronic health records to facilitate clinical research. Clin Res Cardiol 106:1–9

    Article  PubMed  Google Scholar 

  32. Terry AL, Chevendra V, Thind A, Stewart M, Marshall JN, Cejic S (2010) Using your electronic medical record for research: a primer for avoiding pitfalls. Fam Pract 27:121–126

    Article  PubMed  Google Scholar 

  33. Vassar M, Holzmann M (2013) The retrospective chart review: important methodological considerations. J Educ Eval Health Prof 10:12

    Article  PubMed  Google Scholar 

  34. Gilbert EH, Lowenstein SR, Koziol-McLain J, Barta DC, Steiner J (1996) Chart reviews in emergency medicine research: where are the methods? Ann Emerg Med 27:305–308

    Article  PubMed  CAS  Google Scholar 

  35. Lim SY, Lu N, Oza A, Fisher M, Rai SK, Menendez ME, Choi HK (2016) Trends in gout and rheumatoid arthritis hospitalizations in the United States, 1993-2011. JAMA 315:2345–2347

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Acknowledgements

The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Funding

The biostatisticians are partially supported by the National Institute on Minority Health and Health Disparities (U54MD00760131).

Author information

Authors and Affiliations

  1. Lewis and Clark College, Portland, OR, USA

    E.T. Nguyen

  2. Department of Internal Medicine, University of Hawaii, Honolulu, HI, USA

    T. Posas-Mendoza

  3. Hawaii Pacific Health Research Institute, Honolulu, HI, USA

    A.M. Siu

  4. Department of Complementary and Integrative Medicine, University of Hawaii, Honolulu, HI, USA

    H.J. Ahn & S.Y. Choi

  5. Hawaii Pacific Health, Bone and Joint Center, Straub Clinic, 888 S. King Street, Honolulu, HI, 96813, USA

    S.Y. Lim

Authors
  1. E.T. Nguyen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Posas-Mendoza
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A.M. Siu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H.J. Ahn
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S.Y. Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S.Y. Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S.Y. Lim.

Ethics declarations

Conflicts of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nguyen, E., Posas-Mendoza, T., Siu, A. et al. Low rates of osteoporosis treatment after hospitalization for hip fracture in Hawaii. Osteoporos Int 29, 1827–1832 (2018). https://doi.org/10.1007/s00198-018-4553-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-018-4553-2

Keywords

Search

Navigation